Constructing Fe3O4/HA/L-ac Hybrid Nanocomposites as Excellent Antimicrobial Agents and Drug Delivery Vehicles

Open

Hariyanto, Yuanita Amalia (57202791490); Nikmah, Ainun (57208738076); Subadra, S. T. Ulfawanti Intan (57218920346); Susanto, Hendra (57203386604); Sunaryono (55872619200); Nur, Hadi (6602169746); Soontaranoon, Siriwat (6506433449); Tahir, Dahlang (26642188300); Izzuddin, Hubby (57190939617); Taufiq, Ahmad (6507633920)

2026 Journal of Biomedical Materials Research - Part B Applied Biomaterials Article Cited by 3 Quartile

Abstract

In recent decades, death rates from microbial infections and cancer have been increasing. This increase is triggered by the limited effectiveness of existing treatments, such as the use of antibiotics, which are considered less effective due to the development of antibiotic resistance. Furthermore, cancer treatments such as chemotherapy have been reported to produce negative effects on the patient's body. Therefore, alternative treatments are urgently needed, such as developing drug delivery platforms and nanomaterial-based antimicrobial agents. This study aims to develop new hybrid nanocomposites, combining inorganic–organic materials, namely Fe3O4/HA/L-ac (L-ac = L-aspartic acid and HA = hydroxyapatite), as antimicrobial agents and drug delivery vehicles. In this case, Fe3O4, a well-known nanomaterial for antimicrobial agents and drug delivery vehicles, was optimized by combining it with HA and L-ac. The successful formation of nanocomposites was confirmed by X-ray diffraction and Fourier transform infrared spectroscopy. We found that the antimicrobial activity of the composites increased with increasing HA content. HA contributed to the formation of reactive oxygen species and released active ions from nanoparticles through the interaction between the active sites of proteins and antibacterial agents, causing cell lysis. The increased antimicrobial activity was also influenced by electrostatic interactions in the nanocomposite particles, which penetrated the membrane and damaged the microbial cells. As drug delivery vehicles for cancer treatment, the nanocomposites effectively released doxorubicin (DOX), achieving 70% release within the first 45 min and nearly 97%–99% overall. The increased release was associated with a proton exchange mechanism at the primary amine group of DOX. Therefore, the prepared Fe3O4/HA/L-ac hybrid nanocomposites possess high potential for dual applications as antimicrobial agents and drug delivery vehicles. © 2025 Wiley Periodicals LLC.

Affiliations

Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Sam Ratulangi, Indonesia; Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Negeri Malang, Indonesia; Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Negeri Malang, Indonesia; Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Malang, Indonesia; Synchrotron Light Research Institute, Thailand; Department of Physics, Universitas Hasanuddin, Indonesia; Research Center for Energy Materials, National Research and Innovation Agency (BRIN), Indonesia

Research at a Glance

Premium content — register to unlock

Research at a Glance

Register to unlock

Topics & SDG Alignment

Premium content — register to unlock

Topics & SDG Alignment

Register to unlock

Collaboration

Premium content — register to unlock

Collaboration

Register to unlock

Author Profile (Selected)

Premium content — register to unlock

Author Profile (Selected)

Register to unlock

References Overview

Premium content — register to unlock

References Overview

Register to unlock

Journal & Source

Premium content — register to unlock

Journal & Source

Register to unlock

Metadata & Integrity

Premium content — register to unlock

Metadata & Integrity

Register to unlock